Durability of vaccine-induced and natural immunity against COVID-19: a narrative review

Pooley N, Abdool Karim SS, Combadière B, Ooi EE, Harris RC, El Guerche Seblain C, et al. Durability of vaccine-induced and natural immunity against COVID-19: a narrative review. Infect Dis Ther 2023:1-21.

Abstract

Vaccines developed against SARS-CoV-2 have proven to be highly effective in preventing symptomatic infection. Similarly, prior infection with SARS-CoV-2 has been shown to provide substantial protection against reinfection. However, it has become apparent that the protection provided to an individual after either vaccination or infection wanes over time. Waning protection is driven by both waning immunity over time since vaccination or initial infection, and the evolution of new variants of SARS-CoV-2. Both antibody and T/B-cells levels have been investigated as potential correlates of protection post-vaccination or post-infection. The activity of antibodies and T/B-cells provide some potential insight into the underlying causes of waning protection. This review seeks to summarise what is currently known about the waning of protection provided by both vaccination and/or prior infection, as well as the current information on the respective antibody and T/B-cell responses.

 

View related research

Previous
Previous

Clinical characteristics of patients with eosinophilic esophagitis in the UK: a retrospective analysis of the Clinical Practice Research Datalink (CPRD) Database

Next
Next

Cost–consequence analysis of COPD treatment according to NICE and GOLD recommendations compared with current clinical practice in the UK